Aarti Kapoor

Aarti Kapoor is a Partner at Ventac Partners, a life science venture capital and consulting firm operating across Europe, the United States, and Asia. With over 15 years of experience in healthcare and commercial strategy, Kapoor has built a distinguished career at the intersection of biotechnology investing, market intelligence, and strategic consulting.

Kapoor's educational foundation began in India with a Bachelor's degree in Microbiology. She then pursued a Master of Science in Biomedical Sciences from Kingston University in the United Kingdom (1998-1999), followed by an MBA with a specialization in Marketing from Ohio University in the United States (2004-2005). Most recently, she completed executive education at Harvard Online (May 2025 - July 2025), demonstrating her commitment to continuous learning and professional development.

Her entrepreneurial journey began when she conceptualized and established StrataPRO Analytics and Consulting Private Limited, a global healthcare consulting company focused on commercial analytics, market intelligence, and market research consulting. As Co-founder and Director from 2007 to 2009, she developed deep expertise in strategic consulting and market research for the global pharmaceutical and healthcare industry, particularly in building competitive and business intelligence solutions for top pharmaceutical brands.

In 2011, Kapoor joined Ventac Partners as a Partner, a position she held through 2023. At Ventac, she heads market intelligence and advises early-stage biotech and pharma companies on market evaluations and commercialization strategy. The firm's multi-disciplinary Partner and Advisor teams provide services including founding and funding life sciences companies, intellectual property and tech transfer, management consulting, and business development.

Most recently, Kapoor served as Vice President of Commercial Strategy at Oivi, where she led global commercial strategy and helped scale an AI-powered diabetic eye screening solution across India and the United States. She is currently associated with Oncosyne in Oslo, Norway, and actively volunteers as a mentor through Diversify (since August 2025).

Kapoor is multilingual, with native proficiency in Hindi and Punjabi, full professional proficiency in English, and limited working proficiency in Norwegian, reflecting her international career spanning India, the United States, and Scandinavia.

As a Partner at Ventac Partners, Aarti Kapoor focuses on early-stage life science investments, primarily at the Seed and Series A stages. Her investment philosophy centers on advancing healthcare and biotechnology innovations while creating maximum value for both inventors and investors.

Sector Focus:

Stage Preference: Kapoor concentrates on Seed and Series A investments, providing hands-on support to drive innovative technology-based projects from the laboratory to the market. Her typical check sizes range from $100,000 to $5 million, with a sweet spot around $1.5 million.

Value-Add Approach: Drawing on her extensive background in commercial strategy and market intelligence, Kapoor provides portfolio companies with critical support in market evaluations, commercialization strategy, partnerships, and go-to-market planning. Her expertise spans market entry across medtech, pharma, and biotech, with particular strength in helping startups navigate international expansion, especially across India, the United States, and European markets.

What She Looks for in Companies: Kapoor seeks early-stage biotech and pharma companies with innovative technologies that have the potential to address significant unmet medical needs. Her background in market research and competitive intelligence positions her to evaluate both the scientific merit and commercial viability of emerging life science ventures.

• Pharmaceuticals and drug development
• Biotechnology and bioelectronics
• Health IT and Digital Health platforms
• Medical devices and diagnostics
• Health & Hospital Services